Web Results


Jan 3, 2017 ... Amgen Inc. et al v. Sanofi et al, No. 1:2014cv01317 - Document 389 (D. Del. 2017) case opinion from the District of Delaware US Federal District Court.


Rangel v. Sanofi Aventis U.S., LLC et al, No. 6:2010cv01359 - Document 39 (D. Kan. 2012) case opinion from the District of Kansas US Federal District Court.


May 4, 2016 ... Appellant v. SANOFI AVENTIS U.S., LLC;. SANOFI U.S. SERVICES, INC. f/k/a. Sanofi-Aventis U.S. Inc. On Appeal from the United States District Court for the District of New .... by the rolling four months of all units purchased within the market for ... unrestricted formulary access for all FDA-approved Lovenox.


2 See, e.g., Kevin Murphy et al., Competitive Discounts in Antitrust Policy, in 2 OXFORD .... 15 See, e.g., Eisai, Inc. v. Sanofi-Aventis U.S., LLC, 821 F.3d 394, 403 (3d Cir. 2016); Mc-. Wane, Inc. v. FTC, 783 F.3d 814, 823 passim (11th Cir. 2015) (using the term 33 times). ... CRRs covering a small portion of the affected busi-.


May 11, 2016 ... On May 4, 2016, the U.S. Court of Appeals for the Third Circuit announced its decision in Eisai, Inc. v. Sanofi Aventis U.S., LLC,1 rejecting antitrust claims predicated on a supplier's market-share discount program and other promotional tactics. While the court's decision adds some definition to an amorphous ...


Mar 30, 2015 ... FOR THE EASTERN DISTRICT OF PENNSYLVANIA. UNITED STATES OF AMERICA ex rel. YOASH GOHIL,. Plaintiff, v. SANOFI-AVENTIS U.S. INC., et. al. Defendant. : : : : : : : : : : CIVIL ACTION. 02-2964. MEMORANDUM. Stengel, J. March 30, 2015. Yoash Gohil, relator, brings this False Claims Act lawsuit ...


Dec 20, 2017 ... Plaintiffs-Appellees v. SANOFI, AVENTISUB LLC, REGENERON. PHARMACEUTICALS INC., SANOFI-AVENTIS U.S., LLC,. Defendants- Appellants. Appeal from the United States ... The names of all law firms and the partners or associates that appeared for the party or amicus now represented by me in the ...


Feb 5, 2018 ... However, the Patent Owner identified that the '652 patent is involved in the following civil litigations: Sanofi-Aventis U.S. LLC v. Merck Sharp .... Related Matters: According to the petition, the '392 patent is involved in the following civil litigation: Bio-Rad Laboratories, Inc., et al. v. 10X Genomics, Inc., Case ...


Oct 22, 2017 ... Listen to Danielle talk about how she decided to undergo a hematopoietic stem cell transplant and how receiving the transplant led her to remission.